000 | 01608nab a22003137a 4500 | ||
---|---|---|---|
999 |
_c5909 _d5909 |
||
005 | 20250625151453.0 | ||
008 | 180716s2018 xxu||||| |||| 00| 0 eng d | ||
040 | _aAFVC | ||
100 |
_aO'Neil, Adrienne _97697 |
||
245 |
_aThe #MeToo movement : _ban opportunity in public health? _cAdrienne O'Neil, Victor Sojo, Bianca Fileborn, Anna J. Scovelle and Allison Milner |
||
260 |
_bThe Lancet, _c2018 |
||
500 | _aThe Lancet, 2018, 391(10140): 2587–2589 | ||
520 | _aThe worldwide #MeToo movement has brought renewed attention to the issue of sexual harassment in the workplace. Such sexual harassment is a form of gender-based violence at work that is an organisational, criminal, and ethical issue. Despite this renewed focus, sexual harassment is rarely considered a public health issue. The #MeToo movement presents an opportunity for the public health community to consider sexual harassment a health issue with implications for disease prevention and health promotion. (Authors' introduction). Record #5909 | ||
650 |
_aINTERVENTION _9326 |
||
650 |
_aPREVENTION _9458 |
||
650 |
_aPUBLIC HEALTH _9480 |
||
650 |
_aSEXUAL HARASSMENT _9534 |
||
650 |
_aSOCIAL MEDIA _93663 |
||
650 |
_aSTRESS _9582 |
||
650 | 0 |
_aVIOLENCE AGAINST WOMEN _93088 |
|
700 |
_aSojo, Victor _97698 |
||
700 |
_aFileborn, Bianca _93121 |
||
700 |
_aScovelle, Anna J. _97699 |
||
700 |
_aMilner, Allison _97700 |
||
773 | 0 | _tThe Lancet, 2018, 391(10140): 2587–2589 | |
830 |
_aThe Lancet _94435 |
||
856 |
_uhttps://doi.org/10.1016/S0140-6736(18)30991-7 _yRead abstract |
||
942 |
_2ddc _cARTICLE |